1-5 of 5
Authors: R de Jonge
Sort by
Journal Article
P1013 Adverse Events of Methotrexate in Paediatric Inflammatory Bowel Disease: A Retrospective Cohort Study
E Vermeer and others
Journal of Crohn's and Colitis, Volume 19, Issue Supplement_1, January 2025, Page i1875, https://doi.org/10.1093/ecco-jcc/jjae190.1187
Published: 22 January 2025
Journal Article
P536 Outcome of colorectal cancer surveillance in paediatric inflammatory bowel disease: Time for new guidelines?
E Vermeer and others
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Page i1054, https://doi.org/10.1093/ecco-jcc/jjad212.0666
Published: 24 January 2024
Journal Article
P1011 Methotrexate polyglutamates in paediatric inflammatory bowel disease: Novel tool for therapeutic drug monitoring?
E Vermeer and others
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Pages i1827–i1828, https://doi.org/10.1093/ecco-jcc/jjad212.1141
Published: 24 January 2024
Journal Article
P384 A higher red blood cell methotrexate polyglutamate 3 concentration is associated with methotrexate drug-survival in patients with Crohn’s Disease: first results of a prospective cohort
M Van De Meeberg and others
Journal of Crohn's and Colitis, Volume 17, Issue Supplement_1, February 2023, Pages i518–i519, https://doi.org/10.1093/ecco-jcc/jjac190.0514
Published: 30 January 2023
Journal Article
P312 Erythrocyte methotrexate polyglutamate concentrations in patients with Crohn’s Disease: towards a new therapeutic drug monitoring tool
M Van de Meeberg and others
Journal of Crohn's and Colitis, Volume 15, Issue Supplement_1, May 2021, Page S339, https://doi.org/10.1093/ecco-jcc/jjab076.436
Published: 27 May 2021
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals